On this edition of ST, we speak by phone with Giles Slade, a Canadian environmentalist and journalist whose books include " Made to Break: Technology and Obsolescence in America" and "The Big Disconnect: The Story of Technology and Loneliness." Slade's newest book, just out from New Society Publishers, is "American Exodus: Climate Change and the Coming Flight for Survival." As we read of this book at the New Society website: "Some scientists predict the sea will rise 1.5 meters before 2100, but rapidly melting polar ice caps co
(Please note: This interview first aired earlier this year.) Nikola Tesla (1856-1943) was a key player in the electrical revolution that transformed life itself at the dawn of the twentieth century. His inventions, patents, and theoretical work formed the basis of modern AC electricity, and significantly contributed to the development of radio and TV. Like his competitor Thomas Edison, Tesla was also one of America's first celebrity scientists --- yet he's not nearly as famous as Edison today. Why? Our guest is W.
Our guest is author and journalist Andrew Solomon, whose hefty, far-reaching, and award-winning book, "Far From the Tree: Parents, Children, and the Search for Identity," was one of the most widely acclaimed works of nonfiction to be published last year. The book has just appeared in paperback; Solomon joins us today by phone.
Our guest on this edition of ST is a retired petroleum engineering executive and author, John Turley, who will deliver the free-to-the-public Norman M. Hulings, Jr., Memorial Lecture here on the TU campus tomorrow evening (Friday the 15th). Turley's lecture begins at 6pm in the Great Hall of the Allen Chapman Activity Center, which is at 440 S. Gary Avenue.
On this edition of StudioTulsa on Health, guest host John Henning Schumann conducts a fascinating interview with Daniel M. Davis, a Professor of Immunology at the University of Manchester in the UK, where he's also the Director of Research at the Manchester Collaborative Center for Inflammation Research. Dr.
We speak today by phone with Katy Butler, an accomplished journalist whose work has appeared in The New Yorker, The New York Times Magazine, Vogue, The Best American Science Writing, The Best American Essays, and The Best Buddhist Writing.
Why are concussions in sports today --- at the grade school, high school, collegiate, and professional levels; especially over the last decade or so --- becoming more and more common? And what exactly does the term "post-concussion syndrome" (or PCS) refer to? On this encore edition of our program, we listen back to an interesting discussion with Dr. Pat Bellgowan, who's a neuroscientist at The Laureate Institute for Brain Research in Tulsa as well as an Assistant Professor of Psychology at TU. When we originally spoke with Dr.
On this encore edition of ST, we listen back to a discussion from April of this year. At that time, we spoke by phone with the acclaimed science writer, biologist, and neuroscientist, Dr. Robert Sapolsky. He's widely seen as one of our leading experts on stress --- namely, on the ways in which stress affects baboons and other primates, and what this, in turn, tells us about the effects of stress on the human condition.
On this encore edition of ST, we speak with Dr. Pamela Soltis, the curator of the Laboratory of Molecular Systematics and Evolutionary Genetics at the Florida Museum of Natural History at the University of Florida. The work of Dr. Soltis has focused on the use of molecular evidence to reconstruct the patterns of plant evolution, and she has contributed significantly to our understanding of the evolution of flowering plants.
On this edition of ST, as the week-long 2013 Alzheimer's Association International Conference comes to end up in Boston, we speak with Mark Fried, the president and CEO of the Oklahoma Chapter of the Alzheimer's Association. Fried tells us about some interesting new studies and findings that were discussed at this year's conference, namely those related to: the risk and prevention of Alzheimer's disease; advances in early detection; and clinical trials and ongoing therapies.